Skip to content
Open access

Synthesis, quantum chemical calculations, molecular docking, dynamic simulations and ADME predictions of cyclopropylmethyl substituted indole-based hydrazones

Jul 2026 · Discover Chemistry · Vol 3 · 0 citations · 58 references

TL;DR

The results offer a valuable basis for the rational design of new 5-HT2B receptor inhibitors with suitable drug-like properties to become a computationally prioritised candidate for in vitro and in vivo validation.

Abstract

The cyclopropylmethyl substituted indole hydrazone (CPMIH) derivatives were synthesised and characterised using FT-IR and 1H NMR spectroscopic techniques. Their molecular structures and electronic properties were computed by Density Functional Theory (DFT) at the B3LYP/6-31G+(d,p) level theory via Gaussian 16. The molecular parameters of the synthesised hydrazones suggest conjugation across the molecules with possible receptor interaction at the most negative electrostatic potential. The FMO analysis with global reactivity descriptors shows good kinetic stability. The theoretically predicted vibrational spectrum of CPMIH 1 was validated by comparison with the experimental FT-IR spectrum, revealing a strong correlation between the calculated and observed frequencies. Molecular docking studies revealed good binding affinities and interaction profiles with the active site of the Serotonin subtype 5-hydroxytryptamine receptor 2B (5-HT2B). Furthermore, pharmacokinetic, drug-likeness potential, blood–brain barrier (BBB) permeability and human intestinal absorption (HIA) were predicted and compared with the effect of the addition of cyclopropylemthyl substitution through in silico ADME profiling using the SwissADME web tool and the Boiled-egg model. These results offer a valuable basis for the rational design of new 5-HT2B receptor inhibitors with suitable drug-like properties to become a computationally prioritised candidate for in vitro and in vivo validation.

Read PDF

Similar papers

Aug 2026

Synthesis, Computational Chemical Study, Molecular Docking, Dynamics Simulations, and Anti-Diabetic Potential of the Perfluorophenyl Acetamide Derivative

Results indicate this acetamide behaves as a competitive inverse agonist of 5-HT1B subtype receptor and the pharmacophore model of PFPA for interaction with 5-HT1BR was proposed.

Ulviyya Askerova, Gulnara Akverdieva, S. Demukhamedova et al. · 0 citations
Open access Jul 2026

Computational Grasp on Thiadiazole–Oxadiazole Schiff Bases: DFT, ADMET, Molecular Docking, Molecular Dynamics and In Vitro Evaluation of Antibacterial and Cytotoxic Activities

Two novel Schiff bases, PGPS and PGPO, were synthesized using phenyl glyoxal with substituted thiodiazole/oxadiazole, and their molecular structures were substantiated through a combination of spectral analysis and density functional theory.

Archana Tomer, Smriti Bansal, Vishnu Vats et al. · 0 citations
Open access Aug 2026

Straightforward Synthesis, Spectroscopic Characterizations, Molecular Docking, Molecular Dynamics Simulations, and Comprehensive DFT Calculations of Novel Tetrazole 1,5 and 2,5‐Disubstituted Tetrazole Scaffolds

New 1,5‐ and 2,5‐disubstituted tetrazole derivatives were successfully synthesized under phase‐transfer catalysis conditions in good to excellent yields (21%–97%). The structures of the obtained compounds were confirmed by 1H and 13C NMR spectroscopy, as well as single‐crystal X‐ray diffraction analysis. Density functi...

R. Sghyar, Ahmed Chelouan, B. El Ibrahimi et al. · 0 citations
Open access Aug 2026

Structural, Spectroscopic, Quantum Chemical and Molecular Docking Studies on 2-Aminopyridinium Dihydrogen Phosphate: A Potential Multi-Target Bioactive Molecule

This work describes the growth of a proton-transfer single crystal, 2-aminopyridinium dihydrogen phosphate (2APDHP), using the slow solvent evaporation technique and confirmed that the crystal belongs to the monoclinic system.

G. Sivaraj, N. Jayamani, T. M. Viswanathan et al. · 0 citations
Aug 2026

Integrated synthesis, molecular mechanics, quantum mechanics and in vitro studies of triazine derivatives as anticancer compounds.

It was concluded that compound 9b is a promising antiproliferative agent, with an IC50 of 90 μM against all three cancer cell lines and little to no cytotoxicity towards the WS1 cell line, indicating an acceptable safety profile and selective cytotoxicity against cancer cells.

Aayushi Joshi, Abhishek Sharma, Giftson J. Senapathy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.